Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

By C. Urbich, Alexandra Aicher, C. Heeschen, Elisabeth Dernbach, W. Hofmann, A. Zeiher, Stefanie Dimmeler. Journal of Molecular and Cellular Cardiology, 2005

805 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/8082e07dd4eab407ab35cfa0c158c3dfd31cda8e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Shahin Rafii
2. J. Talmadge
3. I. J. Fidler
4. S. Fricker
5. B. Teicher

In Oncology

1. F. Schoen
2. Karen Mendelson
3. J. Talmadge
4. I. J. Fidler
5. S. Fricker
6. B. Teicher

Citations in the corpus

• Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges (2006, background): “172 One potential strategy may be to coat a scaffold with appropriate cell-signaling molecules in an effort to encourage EPC adhesion and differentiation.”
• Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. (2007, neutral): “Data derived from EPC-based cell therapy, despite the beneficial effects, did not clarify whether these cells directly contributed to revascularization of ischemic tissue or rather favoured neo-angiogenesis by a paracrine mechanism.(36,37) Also data relative to the role of EPCs in tumor angiogenesis”
• The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. (2007, background): “Finally, EPCs themselves express and secrete SDF-1 together with VEGF-A [23].”